Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133925) titled 'Daridorexant in Patients with Insomnia and Cognitive Frailty: A Study on Safety and Efficacy' on Oct. 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Huadong Hospital, Fudan University
Condition:
Chronic insomnia disorder, geriatric cognitive frailty, mild neurocognitive decline, geriatric physical frailty syndrome
Intervention:
Daridorexant bridging?switch intervention group:Bridging switch from zolpidem to daridorexant
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-09
Target Sample Size: Daridorexant bridging?switch intervention group:62;Z...